SynerFuse provides a patented Electric Transforaminal Lumbar Interbody Fusion (e-TLIF) procedure that combines spinal fusion with direct nerve stimulation to manage chronic low back and leg pain. This approach aims to reduce the reliance on narcotic pain management following spinal surgery, addressing the significant issue of residual pain experienced by up to 40% of patients post-operation.
Funding
$6.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
A significant percentage of patients, up to 40%, undergoing spinal fusion surgery continue to experience chronic low back and leg pain post-operation. Current treatment options often rely on narcotic pain management, which can lead to complications and is not always effective in addressing the underlying causes of residual pain.
Solution
SynerFuse offers the Electric Transforaminal Lumbar Interbody Fusion (e-TLIF) procedure, an integrated solution designed to address chronic low back and leg pain unaddressed by traditional spinal fusion. The patented e-TLIF procedure combines spinal fusion with direct nerve stimulation using Ultra Low Energy (ULE) Therapy at the point of surgery. This approach aims to provide non-narcotic pain management and improve patient outcomes by directly targeting the source of pain during the fusion process. The company has developed a custom device to deliver the e-TLIF procedure.
Target Audience
The primary target audience includes spinal surgeons and patients undergoing spinal fusion procedures who are at risk of experiencing chronic post-operative pain.
Features
- Patented Electric Transforaminal Lumbar Interbody Fusion (e-TLIF) procedure
- Combines spinal fusion with direct nerve stimulation
- Ultra Low Energy (ULE) Therapy to modulate nerve activity
- Integrated approach to address chronic low back and leg pain
- Designed to reduce the need for narcotic pain management post-surgery
- Custom-developed device for precise delivery of e-TLIF